Cellebrite DI Ltd. (CLBT)
(Real Time Quote from BATS)
$13.82 USD
+0.17 (1.25%)
Updated Aug 6, 2025 03:10 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CLBT 13.82 +0.17(1.25%)
Will CLBT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CLBT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLBT
Match Group (MTCH) Lags Q2 Earnings Estimates
Cellebrite DI Ltd. (CLBT) Tops Q1 Earnings Estimates
CLBT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Arteris, Inc. (AIP) Reports Q1 Loss, Tops Revenue Estimates
CCC Intelligent Solutions Holdings Inc. (CCCS) Meets Q1 Earnings Estimates
SMGZY or CLBT: Which Is the Better Value Stock Right Now?
Other News for CLBT
Greenhaven Road Capital Main Fund Q2 2025 Investor Letter
Cellebrite DI Ltd (CLBT) Secures DOJ Sponsorship for FedRAMP High Authorization | CLBT stock news
Cellebrite (CLBT) Advances FedRAMP High Authorization with DOJ Support | CLBT Stock News
U.S. Department of Justice to Sponsor Cellebrite for FedRAMP ATO | CLBT Stock News
Cellebrite announces U.S. DOJ to sponsor platform for FedRAMP ATO